"Urgent Need to Improve Vaccine Awareness"... SK Bioscience Hosts 'Sky Symposium'

SK Bioscience has strengthened communication with private practitioners through the ‘SKY Symposium’ in preparation for the changing seasons.

On-site at SK Bioscience's 'SKY Symposium'
[Photo by SK Bioscience]

On the 12th, SK Bioscience announced that it held the SKY Symposium, discussing its flagship vaccines and related infectious diseases with general practitioners in major regions nationwide, including Busan, Incheon, Gwangju, and Pangyo in Seongnam, Gyeonggi Province. The SKY Symposium is an annual event organized by SK Bioscience to listen to field voices regarding infectious diseases and vaccination status and to enhance communication with private practitioners.

This year, Professors Park Soo-eun from Yangsan Pusan National University, Kim Seung-hwan, director of Pureun Pediatric Clinic, Kim Young-rae, director of Yonsei Duri Pediatric Clinic, and Professor Yang Eun-seok from Chosun University served as chairpersons. Speakers included Professor Choi Soo-han from Pusan National University, Professor Park Ji-young from Korea University, Professor Lee Hyun-joo from Bundang Seoul National University Hospital, and Professor Lee Sang-hoon from Chonnam National University.

During the four sessions of the symposium, the latest updates on vaccination guidelines for children and adolescents and global trends related to infectious diseases were shared. In particular, following the declaration of COVID-19 endemicity, the incidence of major respiratory infectious diseases such as influenza has increased, emphasizing the importance of continuous vaccination. In this regard, a case study presentation on SKYCellflu, the only cell-cultured influenza vaccine in Korea, provided an opportunity to discuss the characteristics of the cell-cultured vaccine method.

Private practitioners attending the event identified increased fatigue and distrust toward vaccination since the COVID-19 pandemic as the biggest issues. They agreed that improving public awareness of vaccination is the most urgent task, as the incidence of respiratory infectious diseases has risen, with influenza circulating year-round.

Yoo Soo-an, Head of Marketing at SK Bioscience, said, “No matter how good a vaccine developer’s vaccine is, if we do not listen to the voices of clinics and hospitals closest to the public, it is difficult to lead to vaccination. As Korea’s leading vaccine company, SK Bioscience will take the lead in improving the lowered vaccination rates and promoting public health through more active communication.”

This content was produced with the assistance of AI translation services.